The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 01, 2025
Filed:
Feb. 26, 2020
Applicant:
Pantheryx, Inc., Phoenix, AZ (US);
Inventors:
Mark Grabowsky, New York, NY (US);
Raymond J. Playford, Cobham, GB;
Timothy W. Starzl, Boulder, CO (US);
Tania Marchbank, Epsom, GB;
Paul Kelly, Phoenix, AZ (US);
Naheed Choudhry, Phoenix, AZ (US);
Assignee:
PanTheryx, Inc., Phoenix, AZ (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/57 (2015.01); A61K 31/07 (2006.01); A61K 31/355 (2006.01); A61K 31/4415 (2006.01); A61K 31/51 (2006.01); A61K 31/593 (2006.01); A61K 31/714 (2006.01); A61K 33/04 (2006.01); A61K 33/18 (2006.01); A61K 33/34 (2006.01); A61K 33/42 (2006.01); A61K 35/20 (2006.01); A61K 39/00 (2006.01); A61K 39/395 (2006.01); A61K 39/40 (2006.01); A61K 39/42 (2006.01); A61P 1/00 (2006.01);
U.S. Cl.
CPC ...
A61K 35/57 (2013.01); A61K 31/07 (2013.01); A61K 31/355 (2013.01); A61K 31/4415 (2013.01); A61K 31/51 (2013.01); A61K 31/593 (2013.01); A61K 31/714 (2013.01); A61K 33/04 (2013.01); A61K 33/18 (2013.01); A61K 33/34 (2013.01); A61K 33/42 (2013.01); A61K 35/20 (2013.01); A61K 39/39583 (2013.01); A61K 39/40 (2013.01); A61K 39/42 (2013.01); A61P 1/00 (2018.01); A61K 2039/55 (2013.01);
Abstract
Effective and economical compositions and methods are disclosed for the treatment, and prevention of diseases and disorders associated with inflammation and/or damage to the gastrointestinal tract, including environmental enteric dysfunction. Compositions are provided comprising a synergistic combination of colostrum, immune egg, and optionally one or more additional active agents.